Neuron23

AI-drug discovery

Undisclosed programs genetic neurological diseases, inflammatory & autoimmune diseases

Neuron23 is a biotech company aiming to develop precision medicine for complex neurological and immunological diseases. They are leveraging recent advancements in human genetics to identify the underlying causes of diseases. Their state-of-the-art, AI-powered drug discovery platforms are used to design personalized therapies based on a patient's specific genetic makeup. Personalized medicine approaches can minimize side effects often experienced with broad-spectrum therapies. Neuron23 is also able to identify patients who will benefit most from their targeted treatments using their biomarker platforms. By targeting the root cause of the disease at the genetic level, Neuron23 is determined to develop more effective and potentially curative treatments.

Jobs: